DCF — BOLIVAR MEDICAL CENTER
Enterprise Value: $-89.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-89.6M
Enterprise Value
$-28.3M
PV of Cash Flows
$-61.3M
PV of Terminal Value
$-98.8M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $54.1M | $-5.6M | -10.0% | $-7.9M | $-7.2M |
| Year 2 | $55.7M | $-5.2M | -9.0% | $-7.6M | $-6.3M |
| Year 3 | $57.4M | $-4.8M | -8.0% | $-7.2M | $-5.4M |
| Year 4 | $59.1M | $-4.7M | -8.0% | $-7.2M | $-4.9M |
| Year 5 | $60.9M | $-4.7M | -8.0% | $-7.2M | $-4.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-89.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$52.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10892163275255395
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5